View in EDS HTML Full Text PDF Full Text

CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.
Authors: Yang, Na1,2 (AUTHOR), Zhang, Caili1 (AUTHOR), Zhang, Yingchun3 (AUTHOR), Fan, Yuting1,2 (AUTHOR), Zhang, Jing3 (AUTHOR), Lin, Xiaojin1,3 (AUTHOR), Guo, Ting4 (AUTHOR), Gu, Yangzuo5 (AUTHOR), Wu, Jieheng2 (AUTHOR), Gao, Jianmei6 (AUTHOR), Zhao, Xing1,2,3 (AUTHOR) xingzhao@gmc.edu.cn, He, Zhixu1,2,7,8 (AUTHOR) zxhe@zmu.edu.cn
Source: Journal of Translational Medicine. 3/13/2024, Vol. 22, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-024-04990-6